Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

442.33 +5.84 (+1.34%)
Official Closing Price Updated: 4:10 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,498,664
Open 439.96
Bid (Size) 440.10 (1)
Ask (Size) 442.75 (1)
Prev. Close 436.49
Today's Range 436.78 - 444.70
52wk Range 283.11 - 454.95
Shares Outstanding N/A
Dividend Yield 0.77%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
Biogen Hits Buy Zone On A Fresh Win In Alzheimer's Disease; Eli Lilly, Eisai Shares Jump
The news also benefits Biogen's partner Eisai and rival Eli Lilly. 
Via Investor's Business Daily

Performance

YTD
+21.19%
+21.19%
1 Month
+9.43%
+9.43%
3 Month
+40.40%
+40.40%
6 Month
+19.44%
+19.44%
1 Year
+42.19%
+42.19%

More News

Read More
Large-Cap U.S. Equities Showing Narrow Breadth In Year-To-Date Performance
Via Talk Markets
2 Newly Minted AI Stocks to Buy Right Now
Via The Motley Fool
Eli Lilly Unusual Options Activity For May 30
Via Benzinga
Better Dividend Stock: Eli Lilly or Novo Nordisk?
Via The Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today
Via Benzinga
Can Pfizer Stock Double Your Money in 3 Years?
Via The Motley Fool
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
Via Talk Markets
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap — Who Could Be Next To Join Elusive Club?
Via Benzinga
This Pharma's Sales Are So Hot It's Trying to Curb Demand
Via The Motley Fool
Eli Lilly Unusual Options Activity For May 23
Via Benzinga
7 Overvalued Value Stocks to Sell Before June 2023
Via InvestorPlace
3 High-Growth Stocks to Buy Before They Join the Trillion-Dollar Club
Via InvestorPlace
Hagens Berman: Settlement Worth in Excess of $500 Million Reached in Insulin Pricing Class-Action Lawsuit
From Hagens Berman
Via Business Wire
Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected
Via Investor's Business Daily
3 Biotech Stocks Sitting on Huge-Upside Catalysts
Via InvestorPlace
7 Top Stock Tips for June 2023
Via InvestorPlace
Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
Via Benzinga
Ranked: Who Made The Most U.S. Unicorn Acquisitions Since 1997?
Via Talk Markets
7 Stocks That Could Be the Next $2 Trillion-Dollar Companies
Via InvestorPlace
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Via Investor's Business Daily
Microsoft To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
Pfizer Stock Pops: Study Shows Company's Oral Weight Loss Drug Could Be As Effective As Novo Nordic's Ozempic Injection
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.